• Tyrvaya shows consistent outcomes regardless of menopause status

    2 days ago - By Healio

    MONTEREY, Calif. - Women treated with Tyrvaya had consistent outcomes regardless of their menopause status, according to a study presented at the Women in Ophthalmology Summer Symposium.
    Dagny Zhu, MD, and colleagues wrote in a poster presentation that post-menopausal women are at greater risk for dry eye disease due to hormonal dysregulation of ocular secretory glands.
    “By activating the trigeminal parasympathetic pathway, OC-01 (varenicline solution nasal spray 0.03 mg, Oyster Point Pharma), a cholinergic agonist, is believed to increase endogenous tear production,”
    Read more ...